Board Meeting31 Jul 2026, 12:38 pm
Strides Pharma Science Board Approves Unaudited Financial Results
AI Summary
Strides Pharma Science Ltd announced the outcome of its Board Meeting held on July 31, 2026. The Board approved the Unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30, 2026. The financial results, along with the Limited Review Report from statutory auditors B S R & Co. LLP, were presented. The meeting commenced at 10:30 hrs IST and concluded at 12:30 hrs IST. The company will make this information available on its website.
Key Highlights
- Board meeting held on July 31, 2026.
- Unaudited financial results for Q1 FY27 approved.
- Consolidated and standalone results were declared.
- Limited Review Report from auditors B S R & Co. LLP included.
Price Impact
More from STAR